Taipei, Taiwan

Gen-Der Chen

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gen-Der Chen. Retrieved from https://idiyas.com/inventor/gen-der-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gen-Der Chen: Innovator in Zebrafish Drug Screening

Introduction

Gen-Der Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of drug screening through his innovative work with genetically modified zebrafish. His research focuses on utilizing these organisms to advance therapeutic agent identification.

Latest Patents

Gen-Der Chen holds a patent for an invention titled "In vivo assay for neurite outgrowth in zebrafish and its application in drug screening." This patent describes a genetically modified zebrafish embryo that incorporates HBNF cDNA, NGF cDNA, or GDNF cDNA along with a cDNA encoding green fluorescent protein (GFP). This modification induces neurite outgrowth during zebrafish embryonic development, providing a method to identify therapeutic agents effectively.

Career Highlights

Chen is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential applications in drug discovery and development. With 1 patent to his name, he continues to push the boundaries of scientific research.

Collaborations

Throughout his career, Gen-Der Chen has collaborated with notable colleagues, including I-Ching Lu and Chang-Jen Huang. These partnerships have enhanced the scope and impact of his research.

Conclusion

Gen-Der Chen's innovative work in the field of drug screening using genetically modified zebrafish exemplifies the intersection of biology and technology. His contributions are paving the way for advancements in therapeutic agent identification.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…